Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Reprod Immunol. 2008 Jan;77(1):41-50. Epub 2007 Jan 19.

The obstetric antiphospholipid syndrome.

Author information

  • 1Department of Rheumatology and Clinical Immunology, University Medical Center, Utrecht, The Netherlands. r.h.w.m.derksen@umcutrecht.nl

Abstract

The association of persistent presence of circulating antiphospholipid antibodies and thromboembolic events, (recurrent) pregnancy loss or both is termed antiphospholipid syndrome. Pregnancies in women with the syndrome should be regarded as at high-risk for complications. Optimal management consisting of close follow-up and pharmacological treatment can result in about 70-80% live births. Apart from the laboratory diagnosis of the syndrome and pathophysiology, this review will focus on treatment during pregnancy.

PMID:
17239960
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk